Literature DB >> 1874187

The heterogeneity of human chorionic gonadotropin (hCG). I. Characterization of peptide heterogeneity in 13 individual preparations of hCG.

A Kardana1, M M Elliott, M A Gawinowicz, S Birken, L A Cole.   

Abstract

Peptide variations in the alpha-subunit (molecules starting at alpha 3 and alpha 4) and beta-subunit (missing linkages at beta 44-45 and beta 47-48) of hCG have been reported by several investigators. Studies, however, have been limited to standard hCG preparations (purified from large pools of urine) and other hCG samples from mixed urines. In this study we used chromatographic procedures to purify the total hCG content of 13 individual urines, 6 from patients with pregnancy and 7 from those with trophoblast disease (no hCG-containing fractions were excluded). Then, we examined for the first time the peptide variability among individual samples of hCG. We report 1) that individual hCG preparations have nicks (missing linkages) in the beta-subunit, primarily between residue 47-48 (11 of 13 samples) and, less commonly, at the linkage 44-45 or 46-47 (3 of 13 samples); 2) the extent of nicking varies greatly between individual preparations (range, 0-100% of molecules); 3) varying alpha-subunit N-terminal heterogeneity (N-terminus starting at alpha 3 or alpha 4) was also present (range, 0-28% of molecules), but was confined to preparations from individuals with trophoblast disease (6 of 7 samples from trophoblast disease urine, 0 of 6 from pregnancy urine); 4) hCG missing the beta-subunit C-terminal region was also detected (2 of 13 hCG preparations); and 5) 1 of 13 preparations was nicked on the hCG alpha-subunit, between residues 70 and 71. Thus, 12 of 13 individual hCG samples demonstrated at least 1 of 4 different forms of peptide heterogeneity. We conclude that individual hCG samples vary widely in the type and extent of peptide heterogeneity, an observation that is not appreciated when pools of hCG are studied.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874187     DOI: 10.1210/endo-129-3-1541

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Development and characterization of antibodies to a nicked and hyperglycosylated form of hCG from a choriocarcinoma patient: generation of antibodies that differentiate between pregnancy hCG and choriocarcinoma hCG.

Authors:  S Birken; A Krichevsky; J O'Connor; J Schlatterer; L Cole; A Kardana; R Canfield
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

2.  Mitigation of septic shock in mice and rhesus monkeys by human chorionic gonadotrophin-related oligopeptides.

Authors:  N A Khan; M P M Vierboom; C van Holten-Neelen; E Breedveld; E Zuiderwijk-Sick; A Khan; I Kondova; G Braskamp; H F J Savelkoul; W A Dik; B A 't Hart; R Benner
Journal:  Clin Exp Immunol       Date:  2010-03-16       Impact factor: 4.330

3.  Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma.

Authors:  M M Elliott; A Kardana; J W Lustbader; L A Cole
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Molecular heterogeneity of human chorionic gonadotropin in serum and urine from patients with trophoblastic tumors.

Authors:  R Hoermann; G Spoettl; M Grossmann; B Saller; K Mann
Journal:  Clin Investig       Date:  1993-11

5.  Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy.

Authors:  D Glinoer; P De Nayer; C Robyn; B Lejeune; J Kinthaert; S Meuris
Journal:  J Endocrinol Invest       Date:  1993-12       Impact factor: 4.256

Review 6.  The biological and clinical significance of nicks in human chorionic gonadotropin and its free beta-subunit.

Authors:  L A Cole; A Kardana; F C Ying; S Birken
Journal:  Yale J Biol Med       Date:  1991 Nov-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.